Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depemokimab monotherapy without intranasal corticosteroids in Japanese adults with uncontrolled CRSwNP
jRCT2031260158Phase 4Recruiting
- Sponsor
- GSK
- Start
- Jul 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of depemokimab in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by GSK. Started Jul 2026; status: recruiting.
02
Drugs
depemokimab
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on jRCT2031260158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031260158.